Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Comparison of computerized methods for rapid eye movement sleep without atonia detection

Cesari M, Christensen JAE, Kempfner L, Olesen AN, Mayer G, Kesper K, Oertel WH, Sixel-Döring F, Trenkwalder C, Sorensen HBD, Jennum P.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy133.

Concurrent exergaming and transcranial direct current stimulation to improve balance in people with Parkinson's disease: study protocol for a randomised controlled trial

Harris DM, Rantalainen T, Muthalib M, Johnson L, Duckham RL, Smith ST, Daly RM, Teo WP.

Trials. 2018 Jul 16;19(1):387. doi: 10.1186/s13063-018-2773-6.

Comparison of nocturnal symptoms in advanced Parkinson's disease patients with sleep disturbances: pramipexole sustained release versus immediate release formulations

Xiang W, Sun YQ, Teoh HC.

Drug Des Devel Ther. 2018 Jul 4;12:2017-2024. doi: 10.2147/DDDT.S160300. eCollection 2018.

Dyskinesia in Parkinson's disease: a clinical complication and an open scientific question

Carta M, Hirsch E.

J Neural Transm (Vienna). 2018 Aug;125(8):1107. doi: 10.1007/s00702-018-1907-z.

Delta wave notching time is associated with accessory pathway localization in patients with Wolff-Parkinson-White syndrome

Icen YK, Donmez Y, Koca H, Kaypaklı O, Koc M.

J Interv Card Electrophysiol. 2018 Oct;53(1):73-79. doi: 10.1007/s10840-018-0411-6. Epub 2018 Jul 16.

The moral brain and moral behaviour in patients with Parkinson's disease: a review of the literature

Santens P, Vanschoenbeek G, Miatton M, De Letter M.

Acta Neurol Belg. 2018 Sep;118(3):387-393. doi: 10.1007/s13760-018-0986-9. Epub 2018 Jul 16.

Plasma urate and risk of Parkinson's disease: A mendelian randomization study

Kobylecki CJ, Nordestgaard BG, Afzal S.

Ann Neurol. 2018 Aug;84(2):178-190. doi: 10.1002/ana.25292. Epub 2018 Aug 25.

Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson's disease

Sebring K, Shattuck J, Berk J, Boersma I, Sillau S, Kluger BM.

Palliat Med. 2018 Oct;32(9):1522-1528. doi: 10.1177/0269216318785830. Epub 2018 Jul 17.

[Parkinson Disease and Pain - diagnostic and therapeutic approaches to a challenging non-motor symptom]

Buhmann C, Ip CW, Oehlwein C, Tönges L, Wolz M, Reichmann H, Kassubek J.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S48-S58. doi: 10.1055/a-0590-4464. Epub 2018 Jul 17.

[Parkinson's disease and neuroinflammation - Cellular pathology, mechanisms and therapeutic options]

Tönges L, Metzdorf J, Zella S.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S10-S20. doi: 10.1055/s-0044-101608. Epub 2018 Jul 17.

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach

Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA.

Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.

New mode of burst spinal cord stimulation improved mental status as well as motor function in a patient with Parkinson's disease

Kobayashi R, Kenji S, Taketomi A, Murakami H, Ono K, Otake H.

Parkinsonism Relat Disord. 2018 Dec;57:82-83. doi: 10.1016/j.parkreldis.2018.07.002. Epub 2018 Jul 6.

Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases

Neis VB, Rosa PB, Moretti M, Rodrigues ALS.

Curr Pharm Des. 2018;24(20):2283-2302. doi: 10.2174/1381612824666180717160623.

Parkinson's Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasures

Haines DD, Trushin MV, Rose S, Bernard IAS, Mahmoud FF.

Curr Pharm Des. 2018;24(20):2317-2321. doi: 10.2174/1381612824666180717161338.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias